Page 3 - பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் Today - Breaking & Trending Today

WHO Approves Chinese Sinopharm Vaccine - NewZimbabwe.com

BBC
THE World Health Organisation (WHO) has granted emergency approval for the Covid vaccine made by Chinese company Sinopharm.
It is the first vaccine developed by a non-Western country to get WHO backing.
The vaccine has already been given to millions of people in China and elsewhere. The WHO had previously only approved the vaccines made by Pfizer, AstraZeneca, Johnson & Johnson and Moderna.
But individual health regulators in various countries – especially poorer ones in Africa, Latin America and Asia – have approved Chinese jabs for emergency use.
With little data released internationally early on, the effectiveness of the various Chinese vaccines has long been uncertain. ....

United States , Tedros Adhanom Ghebreyesus , Products Institute , World Health Organisation , Spread This , Health Organisation , Latin America , Beijing Biological Products Institute , United Kingdom , ஒன்றுபட்டது மாநிலங்களில் , ப்ராடக்ட்ஸ் நிறுவனம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , பரவுதல் இது , ஆரோக்கியம் ஆர்கநைஸேஶந் , லத்தீன் அமெரிக்கா , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் , ஒன்றுபட்டது கிஂக்டம் ,

Sinopharm vaccine gets WHO nod in potential boost to COVAX pipeline

Middle EastWHO approves Sinopharm vaccine in potential boost to COVAX pipeline
Stephanie Nebehay
5 minute read
The World Health Organization (WHO) approved for emergency use a COVID-19 vaccine from China s state-owned drugmaker Sinopharm on Friday, bolstering Beijing s push for a bigger role in inoculating the world.
The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing.
It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease. Earlier this week, separate WHO experts had expressed concern about the quality of data the company provided on side effects. read more ....

United States , Bruce Aylward , Arnaud Didierlaurent , Tedros Adhanom Ghebreyesus , Alejandro Craviato , Thomson Reuters Trust Principles , World Health Organization , China National Biotec Group , Products Institute , Strategic Advisory Group Of Experts , General Tedros Adhanom Ghebreyesus , Strategic Advisory Group , Beijing Biological Products Institute , Sinovac Biotech , Latin America , Thomson Reuters Trust , ஒன்றுபட்டது மாநிலங்களில் , காயங்கள் ஐலவ்ர்டு , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சீனா தேசிய பயோடெக் குழு , ப்ராடக்ட்ஸ் நிறுவனம் , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் , லத்தீன் அமெரிக்கா , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ,

WHO approves China's Sinopharm vaccine for global use – The Times Of Earth

Photo: Reuters
The World Health Organization approved a COVID-19 vaccine from China’s state-owned drugmaker Sinopharm for emergency use on Friday, a boost to Beijing’s push for a big role in inoculating the world.
The vaccine, one of two main Chinese coronavirus vaccines that collectively have already been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing. It is also the first time the WHO has given emergency use approval to a Chinese vaccine for any infectious disease.
A WHO emergency listing is a signal to national regulators that a product is safe and effective. It also allows it to be included in COVAX, a global programme to provide vaccines mainly for poor countries, which has hit supply problems. ....

United States , Tedros Adhanom Ghebreyesus , Sinovac Biotech , World Health Organization , China National Biotec Group , Products Institute , Strategic Advisory Group Of Experts , General Tedros Adhanom Ghebreyesus , Strategic Advisory Group , Beijing Biological Products Institute , Latin America , ஒன்றுபட்டது மாநிலங்களில் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சீனா தேசிய பயோடெக் குழு , ப்ராடக்ட்ஸ் நிறுவனம் , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் , லத்தீன் அமெரிக்கா ,

WHO approves China's Sinopharm Covid-19 vaccine for emergency use, Europe News & Top Stories

The Straits Times
Sinopharm vaccine gets WHO nod in potential boost to Covax pipeline
Sinopharm becomes the first Covid-19 shot developed by a non-Western country to win the WHO s backing.PHOTO: REUTERS
UpdatedMay 8, 2021, 11:26 am
PublishedMay 7, 2021, 11:24 pm SGT
https://str.sg/Jt7y
They can read the article in full after signing up for a free account.
Share link:
Or share via:
Sign up or log in to read this article in full
Sign up
All done! This article is now fully available for you
Read now
Get unlimited access to all stories at $0.99/month for the first 3 months.
Get unlimited access to all stories at $0.99/month for the first 3 months. ....

United States , Tedros Adhanom Ghebreyesus , Sinovac Biotech , Strategic Advisory Group Of Experts Sage , World Health Organisation , China National Biotec Group , Products Institute , General Tedros Adhanom Ghebreyesus , Strategic Advisory Group , Beijing Biological Products Institute , Latin America , ஒன்றுபட்டது மாநிலங்களில் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சீனா தேசிய பயோடெக் குழு , ப்ராடக்ட்ஸ் நிறுவனம் , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் , லத்தீன் அமெரிக்கா ,

WHO gives emergency approval to first Chinese COVID-19 vaccine, Sinopharm

WHO gives emergency approval to first Chinese COVID-19 vaccine, Sinopharm
The vaccine, one of two main Chinese coronavirus vaccines that have been given to hundreds of millions of people in China and elsewhere, is the first developed by a non-Western country to win WHO backing.
Written By:
Stephanie Nebehay / Reuters |
11:15 am, May 7, 2021
×
A healthcare worker in North Macedonia handles China s Sinopharm coronavirus disease (COVID-19) vaccines at a sport centre, as the country continues its mass inoculation campaign, in Stip, North Macedonia May 6, 2021. REUTERS/Ognen Teofilovski/File Photo
GENEVA, May 7 (Reuters) - The World Health Organization (WHO) approved a COVID-19 vaccine from China s state-owned drugmaker Sinopharm for emergency use on Friday, a boost to Beijing s push for a big role in inoculating the world. ....

United States , Bruce Aylward , Philippa Fletcher , Peter Graff , Arnaud Didierlaurent , Tedros Adhanom Ghebreyesus , Kevin Liffey , Stephanie Nebehay , Sinovac Biotech , China National Biotec Group , Products Institute , Strategic Advisory Group Of Experts , General Tedros Adhanom Ghebreyesus , Strategic Advisory Group , Beijing Biological Products Institute , Latin America , ஒன்றுபட்டது மாநிலங்களில் , காயங்கள் ஐலவ்ர்டு , பிலிப்பா பிளெட்சர் , பீட்டர் கிராஃப் , கெவின் லிஃபீ , சீனா தேசிய பயோடெக் குழு , ப்ராடக்ட்ஸ் நிறுவனம் , பெய்ஜிங் உயிரியல் ப்ராடக்ட்ஸ் நிறுவனம் , லத்தீன் அமெரிக்கா ,